Billable / Specific Code
ICD-10-CM R97.0 is the diagnosis code for Elevated carcinoembryonic antigen [CEA]. This code falls under the section "Abnormal tumor markers" within Chapter 18 — Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R99). It is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
Always refer to the official ICD-10-CM Tabular List for complete coding guidelines. Ensure documentation supports the specificity of the code selected. When in doubt, consult a certified medical coder or the latest CMS guidelines.
Understanding where R97.0 sits in the ICD-10-CM classification helps ensure proper coding:
Yes, R97.0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
R97.0 is the ICD-10-CM diagnosis code for "Elevated carcinoembryonic antigen [CEA]". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
The parent code of R97.0 is R97 ("Abnormal tumor markers"). R97.0 provides a more specific classification within this category.
R97.0 is located in Section R97 — "Abnormal tumor markers" within Chapter 18 of the ICD-10-CM Tabular List.
Use R97.0 when the patients documented diagnosis matches "Elevated carcinoembryonic antigen [CEA]" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Elevated carcinoembryonic antigen [CEA] is R97.0.
Yes, R97.0 can be used as a primary diagnosis code since it is billable and specific.
R97.0 is in Chapter 18 of the ICD-10-CM Tabular List.
Yes, R97.0 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.